PRESS RELEASE published on 07/18/2025 at 07:00, 6 months 14 days ago Press Release: Sanofi completes acquisition of Blueprint Medicines Sanofi completes acquisition of Blueprint Medicines, adding rare immunology disease medicines to its portfolio. The acquisition includes Ayvakit/Ayvakyt for systemic mastocytosis (SM) and elenestinib for SM, enhancing Sanofi's immunology pipeline Acquisition Sanofi Immunology Blueprint Medicines Ayvakit/Ayvakyt
PRESS RELEASE published on 07/18/2025 at 07:00, 6 months 14 days ago Communiqué de presse : Sanofi finalise l’acquisition de Blueprint Medicines Sanofi finalise l’acquisition de Blueprint Medicines, ajoutant des médicaments sur le marché, un pipeline prometteur et l'expertise en mastocytose systémique. Acquisition bénéfique pour Sanofi, sans impact significatif sur les prévisions financières 2025 Acquisition Médicaments Sanofi Blueprint Medicines Mastocytose Systémique
BRIEF published on 07/16/2025 at 07:05, 6 months 16 days ago Sanofi : Désignation "fast track" pour le SAR446597 aux États-Unis FDA Thérapie Génique Sanofi Dégénérescence Maculaire Fast Track
BRIEF published on 07/16/2025 at 07:05, 6 months 16 days ago Sanofi: Fast track designation for SAR446597 in the United States FDA Gene Therapy Sanofi Macular Degeneration Fast Track
PRESS RELEASE published on 07/16/2025 at 07:00, 6 months 16 days ago Press Release: Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration Sanofi's SAR446597 receives fast track designation in the US for geographic atrophy due to age-related macular degeneration, aiming to address unmet medical needs with innovative gene therapy Gene Therapy Sanofi Fast Track Designation Geographic Atrophy SAR446597
PRESS RELEASE published on 07/16/2025 at 07:00, 6 months 16 days ago Communiqué de presse : Le SAR446597 de Sanofi a obtenu la désignation « fast track » aux États-Unis pour le traitement de l’atrophie géographique liée à la dégénérescence maculaire liée à l’âge Sanofi obtient la désignation 'fast track' pour le traitement innovant de l'atrophie géographique liée à la dégénérescence maculaire. Le SAR446597 vise à inhiber des voies clés du complément pour une meilleure efficacité Thérapie Génique Sanofi Dégénérescence Maculaire Fast Track Atrophie Géographique
PRESS RELEASE published on 07/15/2025 at 18:30, 6 months 16 days ago Sanofi: Disclosure of trading in own shares
PRESS RELEASE published on 07/15/2025 at 18:30, 6 months 16 days ago Sanofi : Déclaration des transactions sur actions propres
PRESS RELEASE published on 06/30/2025 at 21:33, 7 months ago Sanofi: Disclosure of trading in own shares
PRESS RELEASE published on 06/30/2025 at 21:33, 7 months ago Sanofi : Déclaration des transactions sur actions propres
Published on 01/31/2026 at 03:15, 1 day 11 hours ago Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 01:40, 1 day 12 hours ago Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/30/2026 at 23:00, 1 day 15 hours ago Avidian Gold Corp. Announces Director Resignation
Published on 01/31/2026 at 15:54, 22 hours 23 minutes ago EQS-Adhoc: Wolford AG: Capital increase will not be implemented
Published on 01/31/2026 at 12:25, 1 day 1 hour ago JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL
Published on 01/31/2026 at 02:45, 1 day 11 hours ago CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 1 day 16 hours ago Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 20:10, 1 day 18 hours ago Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026
Published on 01/30/2026 at 18:40, 1 day 19 hours ago ICADE - Bilan semestriel du contrat de liquidite
Published on 01/30/2026 at 17:45, 1 day 20 hours ago Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 17:45, 1 day 20 hours ago Schneider Electric lance une augmentation de capital réservée aux salariés
Published on 01/30/2026 at 08:30, 2 days 5 hours ago Claude Bernard lance Senior+, un assistant IA conçu pour améliorer la prise en charge des patients les plus âgés